AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting

Abstract Background Next-Generation Sequencing (NGS) enables large-scale and cost-effective sequencing of genetic samples in order to detect genetic variants. After successful use in research-oriented projects, NGS is now entering clinical practice. Consequently, variant analysis is increasingly imp...

Full description

Bibliographic Details
Main Authors: Christian Wünsch, Henrik Banck, Carsten Müller-Tidow, Martin Dugas
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Medical Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12920-020-0668-3
_version_ 1819089024650838016
author Christian Wünsch
Henrik Banck
Carsten Müller-Tidow
Martin Dugas
author_facet Christian Wünsch
Henrik Banck
Carsten Müller-Tidow
Martin Dugas
author_sort Christian Wünsch
collection DOAJ
description Abstract Background Next-Generation Sequencing (NGS) enables large-scale and cost-effective sequencing of genetic samples in order to detect genetic variants. After successful use in research-oriented projects, NGS is now entering clinical practice. Consequently, variant analysis is increasingly important to facilitate a better understanding of disease entities and prognoses. Furthermore, variant calling allows to adapt and optimize specific treatments of individual patients, and thus is an integral part of personalized medicine.However, the analysis of NGS data typically requires a number of complex bioinformatics processing steps. A flexible and reliable software that combines the variant analysis process with a simple, user-friendly interface is therefore highly desirable, but still lacking. Results With AMLVaran (AML Variant Analyzer), we present a web-based software, that covers the complete variant analysis workflow of targeted NGS samples. The software provides a generic pipeline that allows free choice of variant calling tools and a flexible language (SSDL) for filtering variant lists. AMLVaran’s interactive website presents comprehensive annotation data and includes curated information on relevant hotspot regions and driver mutations. A concise clinical report with rule-based diagnostic recommendations is generated.An AMLVaran configuration with eight variant calling tools and a complex scoring scheme, based on the somatic variant calling pipeline appreci8, was used to analyze three datasets from AML and MDS studies with 402 samples in total. Maximum sensitivity and positive predictive values were 1.0 and 0.96, respectively. The tool’s usability was found to be satisfactory by medical professionals. Conclusion Coverage analysis, reproducible variant filtering and software usability are important for clinical assessment of variants. AMLVaran performs reliable NGS variant analyses and generates reports fulfilling the requirements of a clinical setting. Due to its generic design, the software can easily be adapted for use with different targeted panels for other tumor entities, or even for whole-exome data. AMLVaran has been deployed to a public web server and is distributed with Docker scripts for local use.
first_indexed 2024-12-21T22:01:22Z
format Article
id doaj.art-463aa481642a440c82ab5dbc9f503a48
institution Directory Open Access Journal
issn 1755-8794
language English
last_indexed 2024-12-21T22:01:22Z
publishDate 2020-02-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj.art-463aa481642a440c82ab5dbc9f503a482022-12-21T18:48:48ZengBMCBMC Medical Genomics1755-87942020-02-0113111710.1186/s12920-020-0668-3AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care settingChristian Wünsch0Henrik Banck1Carsten Müller-Tidow2Martin Dugas3Institute for Medical Informatics, University of MünsterInstitute for Medical Informatics, University of MünsterDepartment of Medicine V, Hematology, Oncology and Rheumatology, University of HeidelbergInstitute for Medical Informatics, University of MünsterAbstract Background Next-Generation Sequencing (NGS) enables large-scale and cost-effective sequencing of genetic samples in order to detect genetic variants. After successful use in research-oriented projects, NGS is now entering clinical practice. Consequently, variant analysis is increasingly important to facilitate a better understanding of disease entities and prognoses. Furthermore, variant calling allows to adapt and optimize specific treatments of individual patients, and thus is an integral part of personalized medicine.However, the analysis of NGS data typically requires a number of complex bioinformatics processing steps. A flexible and reliable software that combines the variant analysis process with a simple, user-friendly interface is therefore highly desirable, but still lacking. Results With AMLVaran (AML Variant Analyzer), we present a web-based software, that covers the complete variant analysis workflow of targeted NGS samples. The software provides a generic pipeline that allows free choice of variant calling tools and a flexible language (SSDL) for filtering variant lists. AMLVaran’s interactive website presents comprehensive annotation data and includes curated information on relevant hotspot regions and driver mutations. A concise clinical report with rule-based diagnostic recommendations is generated.An AMLVaran configuration with eight variant calling tools and a complex scoring scheme, based on the somatic variant calling pipeline appreci8, was used to analyze three datasets from AML and MDS studies with 402 samples in total. Maximum sensitivity and positive predictive values were 1.0 and 0.96, respectively. The tool’s usability was found to be satisfactory by medical professionals. Conclusion Coverage analysis, reproducible variant filtering and software usability are important for clinical assessment of variants. AMLVaran performs reliable NGS variant analyses and generates reports fulfilling the requirements of a clinical setting. Due to its generic design, the software can easily be adapted for use with different targeted panels for other tumor entities, or even for whole-exome data. AMLVaran has been deployed to a public web server and is distributed with Docker scripts for local use.https://doi.org/10.1186/s12920-020-0668-3GenomicsNGS sequencingVariant callingVariant annotationVariant filteringVariant interpretation
spellingShingle Christian Wünsch
Henrik Banck
Carsten Müller-Tidow
Martin Dugas
AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
BMC Medical Genomics
Genomics
NGS sequencing
Variant calling
Variant annotation
Variant filtering
Variant interpretation
title AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
title_full AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
title_fullStr AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
title_full_unstemmed AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
title_short AMLVaran: a software approach to implement variant analysis of targeted NGS sequencing data in an oncological care setting
title_sort amlvaran a software approach to implement variant analysis of targeted ngs sequencing data in an oncological care setting
topic Genomics
NGS sequencing
Variant calling
Variant annotation
Variant filtering
Variant interpretation
url https://doi.org/10.1186/s12920-020-0668-3
work_keys_str_mv AT christianwunsch amlvaranasoftwareapproachtoimplementvariantanalysisoftargetedngssequencingdatainanoncologicalcaresetting
AT henrikbanck amlvaranasoftwareapproachtoimplementvariantanalysisoftargetedngssequencingdatainanoncologicalcaresetting
AT carstenmullertidow amlvaranasoftwareapproachtoimplementvariantanalysisoftargetedngssequencingdatainanoncologicalcaresetting
AT martindugas amlvaranasoftwareapproachtoimplementvariantanalysisoftargetedngssequencingdatainanoncologicalcaresetting